Clinical and serological characteristics in 128 patients with systemic lupus erythematosus

被引:16
作者
Ghedira, I [1 ]
Sakly, W [1 ]
Jeddi, M [1 ]
机构
[1] CHU Farhat Hached, Lab Microbiol Immunol, Sousse 4000, Tunisia
来源
PATHOLOGIE BIOLOGIE | 2002年 / 50卷 / 01期
关键词
anticardiolipin antibodies; anti-extractable nuclear antigen antibodies antiphospholipid syndrome; ELISA; systemic lupus erythematosus;
D O I
10.1016/S0369-8114(01)00262-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective - To analyse the clinical and serological characteristics of systemic lupus erythematosus (SLE) in the center of Tunisia. Methods - We studied 128 patients with SLE aged one to 73 years. Antinuclear antibodies (ANA) were detected by an immunofluorescence method. Anti-double-stranded DNA (anti-dsDNA) antibodies, anti-extractable nuclear antigen antibodies (anti-Sm, anti-SS-A, anti-SS-B and anti-RNP) and anti-cardiolipin (aCL of IgG, IgA and IgM isotypes) antibodies were detected by ELISA. Results - Malar rsah (71%) and anemia (71%) were the most commun clinical manifestations. Arthritis was seen in 62.5%. Severe kidney damage was observed in 39%. Pericarditis and pleuritis were observed in only 23%. Neurological manifestations (16%) were uncommun. Clinical manifestations of anti-phospholipid syndrome (SAPL) were observed in 15%. ANA were detected in 100%, anti-dsDNA in 76%, anti-Sm in 55.5%, anti-SS-A in 64%, anti-SS-B in 33.6%, anti-RNP in 49%. aCL of IgG, IgA and IgM isotypes were detected in 63.5%, 49% and 40.6% of the patients respectively. The only significant positive clinical associations were those of arthritis with anti-dsDNA antibodies (p = 0.022) and malar rash with anti-SS-A antibodies (p = 0.002). Conclusions - This study suggests that tunisians with SLE present, in general, a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement but low prevalence of major organ damage. (C) 2002 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 39 条
  • [21] Margaux J, 1999, REV RHUM, V66, P102
  • [22] Meyer O, 1997, REV PRATICIEN, V47, P821
  • [23] Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-Americans and Latin Americans
    Molina, JF
    Molina, J
    Garcia, C
    Gharavi, AE
    Wilson, WA
    Espinoza, LR
    [J]. LUPUS, 1997, 6 (01) : 63 - 67
  • [24] SYSTEMIC LUPUS-ERYTHEMATOSUS ON THE CARIBBEAN ISLAND OF CURACAO - AN EPIDEMIOLOGIC INVESTIGATION
    NOSSENT, JC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (11) : 1197 - 1201
  • [25] Pahor A, 1998, WIEN KLIN WOCHENSCHR, V110, P338
  • [26] Pan L. T., 1998, Annals Academy of Medicine Singapore, V27, P21
  • [27] Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease
    Provost, TT
    Watson, R
    SimmonsOBrien, E
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (02) : 147 - 169
  • [28] Utility of anti-Sm, anti-RNP, anti-Ro-SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus
    SanchezGuerrero, J
    Lew, RA
    Fossel, AH
    Schur, PH
    [J]. ARTHRITIS AND RHEUMATISM, 1996, 39 (06): : 1055 - 1061
  • [29] Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus:: a longitudinal study of active and inactive stages of the disease
    Segui, J
    Ramos-Casals, M
    García-Carrasco, M
    de Flores, T
    Cervera, R
    Valdés, M
    Font, J
    Ingelmo, M
    [J]. LUPUS, 2000, 9 (08) : 584 - 588
  • [30] 100 ANTI-RO (SS-A) ANTIBODY-POSITIVE PATIENTS - A 10-YEAR FOLLOW-UP
    SIMMONSOBRIEN, E
    CHEN, S
    WATSON, R
    ANTONI, C
    PETRI, M
    HOCHBERG, M
    STEVENS, MB
    PROVOST, TT
    [J]. MEDICINE, 1995, 74 (03) : 109 - 130